Murine Aβ Over-production Produces Diffuse and Compact Alzheimer-type Amyloid Deposits

Overview

Journal Acta Neuropathol Commun

Publisher Biomed Central

Specialty Neurology

Date 2015 Nov 15

PMID 26566997

Citations 32

Authors

Guilian Xu

Yong Ran

Susan E Fromholt

Chunhua Fu

Anthony T Yachnis

Todd E Golde

David R Borchelt

Affiliations

Soon will be listed here.

Abstract

Introduction: Transgenic overexpression of amyloid precursor protein (APP) genes that are either entirely human in sequence or have humanized Aβ sequences can produce Alzheimer-type amyloidosis in mice, provided the transgenes also encode mutations linked to familial Alzheimer's Disease (FAD). Although transgenic mice have been produced that overexpress wild-type mouse APP, no mice have been generated that express mouse APP with FAD mutations. Here we describe two different versions of such mice that produce amyloid deposits consisting of entirely of mouse Aβ peptides. One line of mice co-expresses mouse APP-Swedish (moAPPswe) with a human presenilin exon-9 deleted variant (PS1dE9) and another line expresses mouse APP-Swedish/Indiana (APPsi) using tetracycline-regulated vectors (tet.moAPPsi).

Results: Both lines of mice that produce mouse Aβ develop amyloid deposits, with the moAPPswe/PS1dE9 mice developing extracellular compact, cored, neuritic deposits that primarily localize to white matter tracts and meningial layers, whereas the tet.moAPPsi mice developed extracellular diffuse cortical/hippocampal deposits distributed throughout the parenchyma.

Conclusions: These findings demonstrate that murine Aβ peptides have the capacity to produce amyloid deposits that are morphologically similar to deposits found in human AD provided the murine APP gene harbors mutations linked to human FAD.

Citing Articles

Integrative proteomics identifies a conserved Aβ amyloid responsome, novel plaque proteins, and pathology modifiers in Alzheimer's disease.

Levites Y, Dammer E, Ran Y, Tsering W, Duong D, Abreha M Cell Rep Med. 2024; 5(8):101669.

PMID: 39127040 PMC: 11384960. DOI: 10.1016/j.xcrm.2024.101669.

Thy1-ApoE4/C/EBPβ double transgenic mice act as a sporadic model with Alzheimer's disease.

Qian Z, Wang Z, Li B, Meng X, Kuang Z, Li Y Mol Psychiatry. 2024; 29(10):3040-3055.

PMID: 38658772 PMC: 11449781. DOI: 10.1038/s41380-024-02565-x.

A C1qTNF3 collagen domain fusion chaperones diverse secreted proteins and anti-Aβ scFvs: Applications for gene therapies.

Moore B, Ran Y, Goodwin M, Komatineni K, McFarland K, Dillon K Mol Ther Methods Clin Dev. 2023; 31:101146.

PMID: 38027063 PMC: 10679951. DOI: 10.1016/j.omtm.2023.101146.

Few-shot prediction of amyloid β accumulation from mainly unpaired data on biomarker candidates.

Yada Y, Naoki H NPJ Syst Biol Appl. 2023; 9(1):59.

PMID: 37993458 PMC: 10665362. DOI: 10.1038/s41540-023-00321-5.

Development of an accelerated cellular model for early changes in Alzheimer's disease.

Xue H, Gate 3rd S, Gentry E, Losert W, Cao K Sci Rep. 2023; 13(1):18384.

PMID: 37884611 PMC: 10603068. DOI: 10.1038/s41598-023-45826-5.

References

Borchelt D, Davis J, Fischer M, Lee M, Slunt H, Ratovitsky T . A vector for expressing foreign genes in the brains and hearts of transgenic mice. Genet Anal. 1996; 13(6):159-63. DOI: 10.1016/s1050-3862(96)00167-2. View

Mayford M, Bach M, Huang Y, Wang L, Hawkins R, Kandel E . Control of memory formation through regulated expression of a CaMKII transgene. Science. 1996; 274(5293):1678-83. DOI: 10.1126/science.274.5293.1678. View

Borchelt D, Ratovitski T, Van Lare J, Lee M, Gonzales V, Jenkins N . Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron. 1997; 19(4):939-45. DOI: 10.1016/s0896-6273(00)80974-5. View

Thinakaran G, Harris C, Ratovitski T, Davenport F, Slunt H, Price D . Evidence that levels of presenilins (PS1 and PS2) are coordinately regulated by competition for limiting cellular factors. J Biol Chem. 1997; 272(45):28415-22. DOI: 10.1074/jbc.272.45.28415. View

Crook R, Verkkoniemi A, Perez-Tur J, Mehta N, Baker M, Houlden H . A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1. Nat Med. 1998; 4(4):452-5. DOI: 10.1038/nm0498-452. View

Atwood C, Moir R, Huang X, Scarpa R, Bacarra N, Romano D . Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis. J Biol Chem. 1998; 273(21):12817-26. DOI: 10.1074/jbc.273.21.12817. View

Guo Q, Fu W, Sopher B, Miller M, Ware C, Martin G . Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice. Nat Med. 1999; 5(1):101-6. DOI: 10.1038/4789. View

Steiner H, Romig H, Grim M, Philipp U, Pesold B, Citron M . The biological and pathological function of the presenilin-1 Deltaexon 9 mutation is independent of its defect to undergo proteolytic processing. J Biol Chem. 1999; 274(12):7615-8. DOI: 10.1074/jbc.274.12.7615. View

Jankowsky J, Melnikova T, Fadale D, Xu G, Slunt H, Gonzales V . Environmental enrichment mitigates cognitive deficits in a mouse model of Alzheimer's disease. J Neurosci. 2005; 25(21):5217-24. PMC: 4440804. DOI: 10.1523/JNEUROSCI.5080-04.2005. View

10.

McGowan E, Pickford F, Kim J, Onstead L, Eriksen J, Yu C . Abeta42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron. 2005; 47(2):191-199. PMC: 1373682. DOI: 10.1016/j.neuron.2005.06.030. View

11.

Jankowsky J, Slunt H, Gonzales V, Savonenko A, Wen J, Jenkins N . Persistent amyloidosis following suppression of Abeta production in a transgenic model of Alzheimer disease. PLoS Med. 2005; 2(12):e355. PMC: 1283364. DOI: 10.1371/journal.pmed.0020355. View

12.

Jankowsky J, Younkin L, Gonzales V, Fadale D, Slunt H, Lester H . Rodent A beta modulates the solubility and distribution of amyloid deposits in transgenic mice. J Biol Chem. 2007; 282(31):22707-20. PMC: 4435736. DOI: 10.1074/jbc.M611050200. View

13.

Kim J, Miller V, Levites Y, West K, Zwizinski C, Moore B . BRI2 (ITM2b) inhibits Abeta deposition in vivo. J Neurosci. 2008; 28(23):6030-6. PMC: 2586000. DOI: 10.1523/JNEUROSCI.0891-08.2008. View

14.

Huang X, Cuajungco M, Atwood C, Hartshorn M, Tyndall J, Hanson G . Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. J Biol Chem. 1999; 274(52):37111-6. DOI: 10.1074/jbc.274.52.37111. View

15.

Verkkoniemi A, Somer M, Rinne J, Myllykangas L, Crook R, Hardy J . Variant Alzheimer's disease with spastic paraparesis: clinical characterization. Neurology. 2000; 54(5):1103-9. DOI: 10.1212/wnl.54.5.1103. View

16.

Morley J, Kumar V, Bernardo A, Farr S, Uezu K, Tumosa N . Beta-amyloid precursor polypeptide in SAMP8 mice affects learning and memory. Peptides. 2001; 21(12):1761-7. DOI: 10.1016/s0196-9781(00)00342-9. View

17.

Cai H, Wang Y, McCarthy D, Wen H, Borchelt D, Price D . BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. Nat Neurosci. 2001; 4(3):233-4. DOI: 10.1038/85064. View

18.

Jankowsky J, Slunt H, Ratovitski T, Jenkins N, Copeland N, Borchelt D . Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomol Eng. 2001; 17(6):157-65. DOI: 10.1016/s1389-0344(01)00067-3. View

19.

Verkkoniemi A, Kalimo H, Paetau A, Somer M, Iwatsubo T, Hardy J . Variant Alzheimer disease with spastic paraparesis: neuropathological phenotype. J Neuropathol Exp Neurol. 2001; 60(5):483-92. DOI: 10.1093/jnen/60.5.483. View

20.

Lesuisse C, Xu G, Anderson J, Wong M, Jankowsky J, Holtz G . Hyper-expression of human apolipoprotein E4 in astroglia and neurons does not enhance amyloid deposition in transgenic mice. Hum Mol Genet. 2001; 10(22):2525-37. DOI: 10.1093/hmg/10.22.2525. View